Eupraxia Pharmaceuticals (EPRX) Current Leases (2022 - 2026)
Eupraxia Pharmaceuticals (EPRX) posted Current Leases of $159,877 for the quarter ended Jun 30, 2026, up 355.9% from $35,065 a year earlier but down 21.4% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Current Leases (2022 - 2026) Analysis & Trends
As of Dec 31, 2025, Eupraxia Pharmaceuticals' Current Leases came in at $78,452, up 9.2% from the prior year.
- Annual Current Leases has increased for three consecutive years, with a three-year compound annual growth rate of 15.9% (years ended Dec 2022 to Dec 2025).
- In prior years, Eupraxia Pharmaceuticals' Current Leases was $71,859 in the year ended Dec 31, 2024 (+34.8%), $53,316 in the year ended Dec 31, 2023 (+5.8%) and $50,403 in the year ended Dec 31, 2022.
- Quarterly Current Leases has run from a low of $14,297 in the quarter ended Sep 30, 2024 to a high of $203,510 in the quarter ended Mar 31, 2026 over five years.
- On a year-over-year basis, Current Leases has increased in each of the last five quarters, with growth averaging 186.4% over the last six quarters.
- According to Business Quant data, Current Leases for the three prior quarters was $203,510 (quarter ended Mar 31, 2026), $78,452 (quarter ended Dec 31, 2025) and $76,136 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 274.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -2.32 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Eupraxia Pharmaceuticals | 328.04 Mn | 326.44 Mn | - | 159,877.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 159,877.00 |
| Mar 31, 2026 | 203,510.00 |
| Dec 31, 2025 | 78,452.00 |
| Sep 30, 2025 | 76,136.00 |
| Jun 30, 2025 | 35,065.00 |
| Mar 31, 2025 | 52,774.00 |
| Dec 31, 2024 | 71,859.00 |
| Sep 30, 2024 | 14,297.00 |
| Jun 30, 2024 | 34,952.00 |
| Dec 31, 2023 | 53,316.00 |
| Dec 31, 2022 | 50,403.00 |
API Access
Eupraxia Pharmaceuticals Current Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-leases&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-leases", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-leases&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();